| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-94 |
Sentence |
denotes |
Esophageal cancer stem cells express PLGF to increase cancer invasion through MMP9 activation. |
| T1 |
0-94 |
Sentence |
denotes |
Esophageal cancer stem cells express PLGF to increase cancer invasion through MMP9 activation. |
| TextSentencer_T2 |
95-196 |
Sentence |
denotes |
Cancer stem cells (CSCs) are a distinct population in tumors and cause cancer relapse and metastasis. |
| T2 |
95-196 |
Sentence |
denotes |
Cancer stem cells (CSCs) are a distinct population in tumors and cause cancer relapse and metastasis. |
| TextSentencer_T3 |
197-300 |
Sentence |
denotes |
Thus, treating CSCs are believed to be potential to cure rapidly growing and highly metastatic cancers. |
| T3 |
197-300 |
Sentence |
denotes |
Thus, treating CSCs are believed to be potential to cure rapidly growing and highly metastatic cancers. |
| TextSentencer_T4 |
301-364 |
Sentence |
denotes |
To date, CSCs in esophageal cancer have not been characterized. |
| T4 |
301-364 |
Sentence |
denotes |
To date, CSCs in esophageal cancer have not been characterized. |
| TextSentencer_T5 |
365-662 |
Sentence |
denotes |
In the current study, we detected significant higher levels of placental growth factor (PLGF) and matrix metalloproteinase 9 (MMP9) in the esophageal cancers with metastasis, compared to those without metastasis, in which the expression levels of PLGF and MMP9 strongly correlated with each other. |
| T5 |
365-662 |
Sentence |
denotes |
In the current study, we detected significant higher levels of placental growth factor (PLGF) and matrix metalloproteinase 9 (MMP9) in the esophageal cancers with metastasis, compared to those without metastasis, in which the expression levels of PLGF and MMP9 strongly correlated with each other. |
| TextSentencer_T6 |
663-763 |
Sentence |
denotes |
Thus, we used a human esophageal cancer cell line, TE-1, to examine the cross talk of PLGF and MMP9. |
| T6 |
663-763 |
Sentence |
denotes |
Thus, we used a human esophageal cancer cell line, TE-1, to examine the cross talk of PLGF and MMP9. |
| TextSentencer_T7 |
764-979 |
Sentence |
denotes |
We found that the levels of PLGF in TE-1 cells positively affected the levels of MMP9, while the levels of MMP9 did not affected the levels of PLGF, suggesting that PLGF may activate MMP9 in esophageal cancer cells. |
| T7 |
764-979 |
Sentence |
denotes |
We found that the levels of PLGF in TE-1 cells positively affected the levels of MMP9, while the levels of MMP9 did not affected the levels of PLGF, suggesting that PLGF may activate MMP9 in esophageal cancer cells. |
| TextSentencer_T8 |
980-1128 |
Sentence |
denotes |
Then, we separated PLGF-positive and PLGF-negative TE-1 cells that had been transfected with a GFP reporter under a PLGF promoter by flow cytometry. |
| T8 |
980-1128 |
Sentence |
denotes |
Then, we separated PLGF-positive and PLGF-negative TE-1 cells that had been transfected with a GFP reporter under a PLGF promoter by flow cytometry. |
| TextSentencer_T9 |
1129-1353 |
Sentence |
denotes |
We found that PLGF-positive cells grew significantly faster than PLGF-negative cells both in vitro and in vivo in a stereotactical implantation model, suggesting that PLGF-positive cells are likely CSCs in esophageal cancer. |
| T9 |
1129-1353 |
Sentence |
denotes |
We found that PLGF-positive cells grew significantly faster than PLGF-negative cells both in vitro and in vivo in a stereotactical implantation model, suggesting that PLGF-positive cells are likely CSCs in esophageal cancer. |
| TextSentencer_T10 |
1354-1529 |
Sentence |
denotes |
Taken together, we demonstrate that PLGF-positive cells appear to be CSCs in esophageal cancer, and they may release PLGF to promote cancer metastasis through MMP9 activation. |
| T10 |
1354-1529 |
Sentence |
denotes |
Taken together, we demonstrate that PLGF-positive cells appear to be CSCs in esophageal cancer, and they may release PLGF to promote cancer metastasis through MMP9 activation. |